Barriers to the safe and effective use of intravenous gentamicin and vancomycin in scottish hospitals, and strategies for quality improvement

European Journal of Hospital Pharmacy

Volumn 22, Issue 1, 2015, Pages 32-37

  Newham, R ^a   Thomson, A H ^a,b   Semple, Y ^a   Dewar, S ^c   Steedman, T ^d   Bennie, M ^a,d  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b Pharmacy Department   (United Kingdom)

^c CROSSHOUSE HOSPITAL   (United Kingdom)

^d INFORMATION SERVICES DIVISION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84919359569     PISSN: 20479956     EISSN: 20479964     Source Type: Journal    
DOI: 10.1136/ejhpharm-2014-000483     Document Type: Article

References (29)

1. World Health Organization. Global priorities for patient safety research: Better knowledge for safer care. 2009. http://whqlibdoc.who.int/publications/2009/9789241598620-eng.pdf (accessed 28 Apr 2014).
2. Royal Pharmaceutical Society. Scottish safety programme credited with drop in mortality. Pharm J 2013;290:262.
3. NHS Scotland. Scottish Patient Safety Programme. 2008. http://www.scottishpatientsafetyprogramme.scot.nhs.uk/programme/news?resid=682 (accessed 12 Dec 2013).
4. Department of Health and Health Protection Agency. Clostridium difficile infection: how to deal with the problem. 2009. http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/documents/digitalasset/dh-093218.pdf (accessed 28 Nov 2012).
5. Berrington A, Borriello SP, Brazier J, et al. National Clostridium difficile standards group: Report to the department of health. J Hosp Infect 2004;56:1-38.
6. Health Protection Scotland and Information Services Division. Report on Antimicrobial Use and Resistance in Humans in 2011. http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Publications/2013-02-26/2013-02-26-SAPG-Report.pdf (accessed 16th December 2012).
7. Scottish Antimicrobials Prescribing Group. Scottish Medicines Consortium: Guidance on use of gentamicin and vancomycin in adults. 2009. http://www.scottishmedicines.org.uk/files/SAPG-Guidance-on-gentamicin-and-vancomycin-policies-revised.pdf (accessed 22 Nov 2010).
8. Rogers MS, Cullen MM, Boxall EM, et al. Improved compliance with a gentamicin prescribing policy after introduction of a monitoring form. J Antimicrobl Chemother 2005;56:566-8.
9. Leong CL, Buising K, Richards M, et al. Providing guidelines and education is not enough: An audit of gentamicin use at The Royal Melbourne Hospital. Intern Med J 2006;36:37-42.
10. Kadambari S, Heath PT, Sharland M, et al. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. J Antimicrob Chemother 2011;66:2647-50.
11. Swartling M, Gupta R, Dudas V, et al. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharma 2012;34:282-5.
12. Minne L, Eslami S, Kuiper RA, et al. Five years of therapeutic drug monitoring in the intensive care did not change vancomycin prescription behaviour: perceived needs for decision support. Minerva Anestesiol 2012;78:684-92.
13. Traugott KA, Maxwell PR, Green K, et al. Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. Am J Health Syst Pharm 2011;68:347-52.
14. Charani E, Edwards R, Sevdalis N, et al. Behavior Change Strategies to influence antimicrobial prescribing in acute care: A systematic review. Clin Infect Dis 2011;53:651-62.
15. Gentamicin and Vancomycin Quality Improvement Programme Team. NHS Scotland Gentamicin and Vancomycin (GaV) Quality Improvement Programme Report- January 2012.
16. Ritchie J. The application of qualitative methods to social research. In: Ritchie J, Lewis J, eds. Qualitative research practice: A guide for social science students and researchers. London: Sage, 2003:24-46.
17. Stevenson FA, Britten N, Barry CA, et al. Qualitative methods and prescribing research. J Clin Pharm Ther 2000;25:317-24.
18. Department of Health. Governance arrangements for NHS Research Ethics Committees. 2001. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-4005727 (accessed 23 May 2012).
19. Pope C, Ziebland S, Mays N. Qualitative research in health care-analysing qualitative data (reprinted from qualitative research in health care). BMJ 2000;320:114-16.
20. Ritchie J, Spencer L, O'Connor W, eds. Carrying out qualitative analysis. London: Sage Publications Ltd., 2003.
21. Barlow G, Nathwani D, Myers E, et al. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia. J Antimicrob Chemother 2008;61:442-51.
22. Majumdar SR, Simpson SH, Marrie TJ. Physician-perceived barriers to adopting a critical pathway for unity-acquired pneumonia. Jt Comm J Qual Saf 2004;30:387-95.
23. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA-J Am Med Assoc 1999;282:1458-65.
24. Mattick K, Kelly N, Rees C. A window into the lives of junior doctors: narrative interviews exploring antimicrobial prescribing experiences. J Antimicrob Chemother 2014 doi:10.1093/jac/dku093.
25. Michie S, Richardson M, Johnston M, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: Building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:81-95.
26. Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Sci 2011;6:42.
27. Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: Effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012(6):CD000259.
28. Semple Y, Dewar S, Thomson A, et al. National study of gentamicin and vancomycin use to inform development of a quality improvement programme. Federation of Infection Societies Conference. Birmingham, 2013.
29. Semple Y, Dewar S, Thomson A, et al. Development of a quality improvement programme to improve patient safety and clinical effectiveness of gentamicin and vancomycin. Chester: United Kingdom Clinical Pharmacy Association, 2013.